期刊的影响因子--文章列表

期刊文章列表
Tingting Yang¹，Yuzhu Hu^1,2，Junming Miao¹，Jing Chen¹，Jiagang Liu¹，Yongzhong Cheng¹，Xiang Gao¹（Department of Neurosurgery and Institute of Neurosurgery，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，West China Medical School，Sichuan University and Collaborative Innovation Center for Biotherapy；Department of Medical Oncology，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，West China Medical School，Sichuan University and Collaborative Innovation Center for Biotherapy）.A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation,apoptosis and M2 macrophages polarization[J].Acta Pharmaceutica Sinica B,2022,第6期 Yurong Lai¹，Xiaoyan Chu²，Li Di³，Wei Gao^2,4，Yingying Guo⁵，Xingrong Liu^6,1，Chuang Lu⁷，Jialin Mao⁸，Hong Shen⁹，Huaping Tang¹⁰，Cindy Q.Xia¹¹，Lei Zhang¹²，Xinxin Ding¹³（Drug Metabolism，Gilead Sciences Inc.；Department of Pharmacokinetics，Pharmacodynamics and Drug Metabolism，Merck & Co.，Inc.；Pharmacokinetics，Dynamics and Metabolism，Pfizer Worldwide Research and Development；Translational Medicine，EMD Serono Research & Development Institute，Inc.；Eli Lilly and Company；Drug Metabolism and Pharmacokinetics Drug Metabolism and Pharmacokinetics，Accent Therapeutics，Inc. Department of Drug Metabolism and Pharmacokinetics，Genentech，A Member of the Roche Group；Drug Metabolism and Pharmacokinetics Department，Bristol-Myers Squibb Company；Bioanalysis and Biomarkers，Glaxo Smith Kline；Department of Drug Metabolism and Pharmacokinetics，Takeda Pharmaceuticals International Co.；Office of Research and Standards，Office of Generic Drugs，CDER，FDA；Department of Pharmacology and Toxicology，College of Pharmacy，University of Arizona）.Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development[J].Acta Pharmaceutica Sinica B,2022,第6期 Jiayi Ye^1,2，Bo Hou^1,3，Fangmin Chen^1,2，Shunan Zhang^1,3，Muya Xiong^2,4，Tianliang Li¹，Yechun Xu^2,4,5，Zhiai Xu³，Haijun Yu^1,2（State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；School of Chemistry and Molecular Engineering，East China Normal University；CAS Key Laboratory of Receptor Research，and Drug Discovery and Design Center，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第6期 Ozioma Udochukwu Akakuru¹，Zhoujing Zhang²，M.Zubair Iqbal^1,3，Chengjie Zhu¹，Yewei Zhang²，Aiguo Wu¹（Cixi Institute of Biomedical Engineering，International Cooperation Base of Biomedical Materials Technology and Application，Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices，Zhejiang Engineering Research Center for Biomedical Materials，Ningbo Institute of Materials Technology and Engineering，CAS；School of Medicine，Southeast University；School of Materials Science and Engineering，Zhejiang Sci-Tech University）.Chemotherapeutic nanomaterials in tumor boundary delineation：Prospects for effective tumor treatment[J].Acta Pharmaceutica Sinica B,2022,第6期 Lichan Tu^1,2,3，Xinbo Cai²，Yifeng Zhang^1,2，Yuru Tong⁴，Jian Wang⁵，Ping Su^5,6，Yun Lu²，Tianyuan Hu⁷，Yunfeng Luo²，Xiaoyi Wu²，Dan Li⁴，Luqi Huang⁵，Wei Gao^1,2（Beijing Shijitan Hospital，Capital Medical University；School of Traditional Chinese Medicine，Capital Medical University；School of Medicine，Zhejiang University City College；School of Pharmaceutical Sciences，Capital Medical University；State Key Laboratory Breeding Base of Dao-di Herbs，National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences；Department of Chemistry，The Scripps Research Institute；School of Pharmacy，Hangzhou Normal University）.Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii[J].Acta Pharmaceutica Sinica B,2022,第6期 Menghuan Tang^1,2，Kai Lin^2,3，Mythili Ramachandran²，Longmeng Li²，Hongye Zou²，Huzhi Zheng¹，Zhao Ma^2,4，Yuanpei Li²（Key Laboratory of Luminescent and Real-Time Analytical Chemistry，Ministry of Education，College of Chemistry and Chemical Engineering，Southwest University；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine；College of Food Science and Engineering，Ocean University of China；Department of Medicinal Chemistry，Key Laboratory of Chemical Biology (MOE)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.A mitochondria-targeting lipid——small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model[J].Acta Pharmaceutica Sinica B,2022,第6期 Debin Zheng¹，Jingfei Liu¹，Limin Xie¹，Yuhan Wang¹，Yinghao Ding²，Rong Peng¹，Min Cui³，Ling Wang²，Yongjie Zhang³，Chunqiu Zhang¹，Zhimou Yang¹（Key Laboratory of Bioactive Materials，Ministry of Education，State Key Laboratory of Medicinal Chemical Biology，College of Life Sciences，Collaborative Innovation Center of Chemical Science and Engineering，National Institute of Functional Materials，Nankai University；College of Pharmacy，Nankai University；Department of Human Anatomy，Nanjing Medical University）.Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death[J].Acta Pharmaceutica Sinica B,2022,第6期 Fangfang Lai¹，Ming Ji¹，Lei Huang¹，Yunchen Wang¹，Nina Xue¹，Tingting Du¹，Kai Dong²，Xiaoqing Yao²，Jing Jin¹，Zhiqiang Feng³，Xiaoguang Chen¹（Department of Pharmacology，State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Tianjin Chase Sun Pharmaceutical Co.，Ltd.；Department of Pharmacochemistry，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer[J].Acta Pharmaceutica Sinica B,2022,第6期 Wei Wang¹，Shuo Feng²，Zhuyifan Ye¹，Hanlu Gao¹，Jinzhong Lin²，Defang Ouyang¹（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；State Key Laboratory of Genetic Engineering，School of Life Sciences，Zhongshan Hospital，Fudan University）.Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm[J].Acta Pharmaceutica Sinica B,2022,第6期 Jiaxing Li^1,2，Xiao Wang^1,2，Jiayu Ding^1,2，Yasheng Zhu^1,2，Wenjian Min^1,2，Wenbing Kuang^1,2，Kai Yuan^1,2，Chengliang Sun^1,2，Peng Yang^1,2（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization，China Pharmaceutical University；Department of Medicinal Chemistry，School of Pharmacy，China Pharmaceutical University）.Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell[J].Acta Pharmaceutica Sinica B,2022,第6期 Peilu Song^1,2，Fan Zhao³，Dahong Li^1,4，Jiqiang Qu⁵，Miao Yao⁶，Yuan Su¹，Hanxun Wang¹，Miaomiao Zhou⁶，Yujie Wang¹，Yinli Gao¹，Feng Li⁷，Dongmei Zhao¹，Fengjiao Zhang⁶，Yu Rao²，Mingyu Xia⁵，Haitao Li³，Jian Wang¹，Maosheng Cheng¹（Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education，Shenyang Pharmaceutical University；MOE Key Laboratory of Protein Sciences，School of Pharmaceutical Sciences，MOE Key Laboratory of Bioorganic Phosphorus Chemistry Chemical Biology，Tsinghua University；MOE Key Laboratory of Protein Sciences，Beijing Advanced Innovation Center for Structural Biology，Tsinghua-Peking Joint Center for Life Sciences，School of Life Sciences and School of Medicine，Tsinghua University；School of Traditional Chinese Materia Medica，Shenyang Pharmaceutical University；School of Life Science and Biopharmaceutics，Shenyang Pharmaceutical University；Wuya College of Innovation，Shenyang Pharmaceutical University；Department of Cell Biology，Key Laboratory of Cell Biology，Ministry of Public Health，and Key Laboratory of Medical Cell Biology，Ministry of Education，China Medical University）.Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells[J].Acta Pharmaceutica Sinica B,2022,第6期 Ying Liu^1,2，Yu Han³，Shizhu Chen⁴，Jingjie Liu²，Dajiang Wang²，Yifei Huang²（Department of Ophthalmology，Beijing Rehabilitation Hospital，Capital Medical University；Department of Ophthalmology，Chinese PLA General Hospital；College of Chemistry & Environmental Science，Chemical Biology Key Laboratory of Hebei Province，Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education，Hebei University；China Resources Pharmaceutical Group Limited）.Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma[J].Acta Pharmaceutica Sinica B,2022,第6期 Ying Wu¹，Congying Pu²，Yixian Fu²，Guoqiang Dong¹，Min Huang²，Chunquan Sheng¹（School of Pharmacy，Second Military Medical University；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，University of Chinese Academy of Sciences）.NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion[J].Acta Pharmaceutica Sinica B,2022,第6期 Jiao Xue，Yining Zhu，Shuting Bai，Chunting He，Guangsheng Du，Yuandong Zhang，Yao Zhong，Wenfei Chen，Hairui Wang，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma[J].Acta Pharmaceutica Sinica B,2022,第6期 Shanmin Zheng^1,2，Jiawei Guo²，Fangyuan Cheng²，Zhengquan Gao³，Lei Du²，Chunxiao Meng¹，Shengying Li^2,4，Xingwang Zhang²（School of Life Sciences，Shandong University of Technology；State Key Laboratory of Microbial Technology，Shandong University；School of Pharmacy，Binzhou Medical University；Laboratory for Marine Biology and Biotechnology，Qingdao National Laboratory for Marine Science and Technology）.Cytochrome P450s in algae：Bioactive natural product biosynthesis and light-driven bioproduction[J].Acta Pharmaceutica Sinica B,2022,第6期 Zhiran Ju^1,2，Menglan Li¹，Junde Xu¹，Daniel C.Howell¹，Zhiyun Li¹，Fen-Er Chen^1,3,4（Institute of Pharmaceutical Science and Technology，Zhejiang University of Technology；Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals，Zhejiang University of Technology；Engineering Center of Catalysis and Synthesis for Chiral Molecules，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs）.Recent development on COX-2 inhibitors as promising anti-inflammatory agents：The past 10 years[J].Acta Pharmaceutica Sinica B,2022,第6期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第6期 Piao Luo^1,2，Dandan Liu¹，Qian Zhang¹，Fan Yang^3,4，Yin-Kwan Wong¹，Fei Xia¹，Junzhe Zhang¹，Jiayun Chen¹，Ya Tian¹，Chuanbin Yang³，Lingyun Dai³，Han-Ming Shen⁵，Jigang Wang^1,2,3,4,6（Artemisinin Research Center，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Central People's Hospital of Zhanjiang；Department of Urology，the Second Clinical Medical College，Jinan University(Shenzhen People's Hospital)；Integrated Chinese and Western Medicine Postdoctoral Research Station，Jinan University；Faculty of Health Sciences，University of Macau；Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University）.Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1[J].Acta Pharmaceutica Sinica B,2022,第5期 Baoyi Guan^1,2，Jinlin Tong¹，Haiping Hao³，Zhixu Yang¹，Keji Chen^1,2，Hao Xu^1,2，Anlu Wang^1,2（Xiyuan Hospital，China Academy of Chinese Medical Sciences；National Clinical Research Center for Chinese Medicine Cardiology；State Key Laboratory of Natural Medicines，China Pharmaceutical University）.Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases[J].Acta Pharmaceutica Sinica B,2022,第5期 Chan Feng^1,2,3，Yongjiang Li^2,4，Bijan Emiliano Ferdows²，Dylan Neal Patel²，Jiang Ouyang²，Zhongmin Tang²，Na Kong²，Enguo Chen^1,3，Wei Tao²（Department of Respiratory Medicine，Sir Run Run Shaw Hospital，Zhejiang University School of Medicine；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women's Hospital，Harvard Medical School；Cancer Center，Zhejiang University；Department of Pharmacy，the Second Xiangya Hospital of Central South University；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Emerging vaccine nanotechnology：From defense against infection to sniping cancer[J].Acta Pharmaceutica Sinica B,2022,第5期 Yuhong Zhang¹，Yanqing Ding¹，Min Li¹，Jing Yuan²，Youhui Yu²，Xueying Bi¹，Huiqi Hong¹，Jiantao Ye¹，Peiqing Liu¹（Department of Pharmacology and Toxicology，School of Pharmaceutical Sciences，National and Local United Engineering Lab of Druggability and New Drugs Evaluation，Sun Yat-sen University；State Key Laboratory of Oncology in Southern China，Collaborative Innovation Center for Cancer Medicine，Sun Yat-sen University Cancer Center）.MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B[J].Acta Pharmaceutica Sinica B,2022,第5期 Xuesong Li¹，Ruigong Zhu¹，Hong Jiang¹，Quanwen Yin¹，Jiaming Gu¹，Jiajing Chen¹，Xian Ji¹，Xuan Wu¹，Haiping Fu¹，Hui Wang¹，Xin Tang¹，Yuanqing Gao¹，Bingjian Wang²，Yong Ji^1,3，Hongshan Chen^1,3,4,2（Key Laboratory of Cardiovascular and Cerebrovascular Medicine，School of Pharmacy，Nanjing Medical University；Department of Cardiology，Huai'an First People's Hospital Affiliated with Nanjing Medical University；Key Laboratory of Targeted Intervention of Cardiovascular Disease，Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University；Department of Cardiothoracic Surgery，the Second Affiliated Hospital of Nanjing Medical University）.Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis[J].Acta Pharmaceutica Sinica B,2022,第5期 Kun Luo^1,2，Wenting Huang^1,2，Liansheng Qiao^1,2，Xiaoling Zhang³，Di Yan⁴，Zhiyu Ning^1,2，Chengmei Ma³，Honglei Dang³，Dong Wang⁴，Hongyan Guo³，Lan Xie^1,2,3，Jing Cheng^1,2,3,4（State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University；Medical Systems Biology Research Center，School of Medicine，Tsinghua University；National Engineering Research Center for Beijing Biochip Technology；School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine）.Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation[J].Acta Pharmaceutica Sinica B,2022,第5期 Xiaoli Pan¹，Junping Pei¹，Aoxue Wang¹，Wen Shuai¹，Lu Feng¹，Faqian Bu¹，Yumeng Zhu¹，Lan Zhang²，Guan Wang¹，Liang Ouyang¹（State Key Laboratory of Biotherapy and Cancer Center，Innovation Center of Nursing Research，Nursing Key Laboratory of Sichuan Province，National Clinical Research Center for Geriatrics，West China Hospital，and Collaborative Innovation Center of Biotherapy，Sichuan University；Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs，School of Life Science and Engineering，Southwest Jiaotong University）.Development of small molecule extracellular signal-regulated kinases（ERKs） inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第5期 Ting Chen^1,2，Bo Zhuang^2,3，Yueqi Huang²，Yan Liu²，Bochuan Yuan²，Wanmei Wang²，Tianyu Yuan²，Lina Du^1,2，Yiguang Jin^1,2（Guangdong Pharmaceutical University；Department of Pharmaceutical Sciences，Beijing Institute of Radiation Medicine；Department of Chemical Defense，Institute of NBC Defense）.Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis[J].Acta Pharmaceutica Sinica B,2022,第5期 Dandan Shen^1,2，Bo Wang^1,2，Ya Gao^1,2，Lijuan Zhao^1,2,3，Yaping Bi^1,2，Jinge Zhang^1,2，Ning Wang⁴，Huiqin Kang^1,2，Jingru Pang^1,2，Ying Liu^1,2，Luping Pang^1,2，Zhe-Sheng Chen⁵，Yi-Chao Zheng^1,2,3，Hong-Min Liu^1,2,3（Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education of China，Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University；Key Laboratory of Henan Province for Drug Quality and Evaluation，Institute of Drug Discovery and Development，School of Pharmaceutical Sciences，Zhengzhou University；State Key Laboratory of Esophageal Cancer Prevention & Treatment，Academy of Medical Sciences，Zhengzhou University；The School of Chinese Medicine，The University of Hong Kong；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University）.Detailed resume of RNA m~6A demethylases[J].Acta Pharmaceutica Sinica B,2022,第5期 Wei Gao¹，Hongxiang Hu¹，Lipeng Dai¹，Miao He¹，Hebao Yuan¹，Huixia Zhang¹，Jinhui Liao¹，Bo Wen¹，Yan Li²，Maria Palmisano²，Mohamed Dit Mady Traore¹，Simon Zhou²，Duxin Sun¹（Department of Pharmaceutical Sciences，College of Pharmacy，University of Michigan；Translational Development and Clinical Pharmacology，Bristol Myers Squibb）.Structure-tissue exposure/selectivity relationship（STR） correlates with clinical efficacy/safety[J].Acta Pharmaceutica Sinica B,2022,第5期首页上一页 3 4 5 6 7 下一页尾页共有11页，转到页

期刊文章列表